home / stock / ocpny / ocpny news


OCPNY News and Press, Olympus Corp Sponsored ADR From 07/15/22

Stock Information

Company Name: Olympus Corp Sponsored ADR
Stock Symbol: OCPNY
Market: OTC

Menu

OCPNY OCPNY Quote OCPNY Short OCPNY News OCPNY Articles OCPNY Message Board
Get OCPNY Alerts

News, Short Squeeze, Breakout and More Instantly...

OCPNY - ClearBridge International Growth ADR Strategy Commentary Q2 2022

Growth stocks continued to trail value through challenging macro and market conditions but the magnitude of underperformance has been narrowing, supporting Strategy results. To manage through the myriad uncertainties in the current environment, we continue to rely on secular and struc...

OCPNY - ClearBridge International Growth EAFE Portfolio Manager Commentary Q2 2022

Growth stocks continued to trail value through challenging macro and market conditions but the magnitude of underperformance has been narrowing, supporting Strategy results. To manage through the myriad uncertainties in the current environment, we continue to rely on secular and struc...

OCPNY - Olympus to Use 100% Renewable Electricity at R&D and Manufacturing Sites in Japan

Olympus to Use 100% Renewable Electricity at R&D and Manufacturing Sites in Japan TOKYO, June 14, 2022 - (ACN Newswire) - Olympus Corporation ("Olympus" - Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) announces that from April 2022, the com...

OCPNY - ClearBridge Investments Global Growth Strategy Q1 2022 Commentary

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. A sharp spike in bond yields pressured growth stocks and ...

OCPNY - ClearBridge International Growth EAFE Strategy Portfolio Manager Commentary Q1 2022

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. A sharp spike in bond yields pressured growth stocks and ...

OCPNY - ClearBridge International Growth ADR Strategy Portfolio Manager Commentary Q1 2022

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. A sharp spike in bond yields pressured growth stocks and ...

OCPNY - VGI Partners Global Investments Investor Letter - Full Year 2021

VGI Partners Global Investments Limited is an Australia-based investment company. The Company’s Investment Strategy is to create a concentrated Portfolio, predominantly comprised of Long and Short Positions in global listed securities, actively managed with a focus on capital prese...

OCPNY - Should You Buy the Dip in Intuitive Surgical?

Shares of global medical technology pioneer Intuitive Surgical (ISRG) have been foundering of late because investors are concerned about the COVID-19 pandemic’s adverse impact on the company’s procedure volumes. But as the omicron variant threat recedes, will ISRG’s stock...

OCPNY - Is ResMed a Buy Under $250?

Currently trading at less than $250, ResMed Inc. (RMD) exhibited solid fundamental performance in its last reported quarter based on its strong sales growth across its product portfolio. So, given favorable analysts' sentiments about the stock and the company’s strong profitability, is...

OCPNY - Is Biolase a Good Medical Device Stock to Add to Your Portfolio?

Dental-industry-focused medical device company BIOLASE (BIOL) recently received an extension from Nasdaq to meet the exchange’s minimum bid price requirement and reported revenue growth in the third quarter. However, is it wise to add the stock to one’s portfolio even though BIO...

Previous 10 Next 10